Cargando…
Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have become the standard treatment for recurrent or metastatic head and neck cancer (RM-HNC). However, many patients fail to benefit from the treatment. Previous studies have revealed that tumor burden predicts the efficacy of ICIs, but this association remains un...
Autores principales: | Matoba, Takuma, Minohara, Kiyoshi, Kawakita, Daisuke, Takano, Gaku, Oguri, Keisuke, Murashima, Akihiro, Nakai, Kazuyuki, Iwaki, Sho, Tsuge, Hiroshi, Tanaka, Nobukazu, Imaizumi, Sae, Hojo, Wataru, Matsumura, Ayano, Tsukamoto, Koji, Esaki, Shinichi, Iwasaki, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395325/ https://www.ncbi.nlm.nih.gov/pubmed/35996017 http://dx.doi.org/10.1038/s41598-022-18611-z |
Ejemplares similares
-
Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
por: Minohara, Kiyoshi, et al.
Publicado: (2021) -
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
por: Minohara, Kiyoshi, et al.
Publicado: (2023) -
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
por: Takano, Gaku, et al.
Publicado: (2020) -
Assessment of semicircular canal function in benign paroxysmal positional vertigo using the video head impulse test and caloric test
por: Kabaya, Kayoko, et al.
Publicado: (2023) -
Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan
por: Kawakita, Daisuke, et al.
Publicado: (2022)